Excellent partnership! NovoCure, Merck Team Up on Phase II Lung Cancer Trial! Aim to develop Tumor Treating Fields with Merck’s anti-PD-1 therapy, Keytruda! $NVCR $MRK #cancer #lungcancer 
https://t.co/ab8OIjBPwm